human health

TESTs
 

 

A RAPID AND PRECISE DIAGNOSTIC TEST FOR THE DETECION OF COVID-19 IN 20 MINUTES

Coronavirus Disease 2019 (COVID-19) is an acute respiratory illness caused by infection with the SARS-CoV-2, which was initially reported to WHO in Wuhan, China, on December 31, 2019. The SARS-CoV-2 is from the same family of viruses as Severe Acute Respiratory Syndrome (SARS) and spreads from person to person. Virus-laden droplets from an infected person can be transmitted through the nose, eyes, or mouth of another.

The VitaPCR™ SARS-CoV-2 Gen 2 Assay performed on the VitaPCR™ Instrument is a rapid molecular in vitro diagnostic test utilizing a real-time reverse transcription polymerase chain reaction(rRT-PCR) amplification technology for the qualitative detection of SARS-CoV-2 RNA in nasopharyngeal or oropharyngeal swabs from patients with signs and symptoms of respiratory infection.

 

 

 

VitaPCRTM: ACCURATE DIAGNOSTICS, WHENEVER AND WHEREVER YOU NEED IT.

Combining a simplified 2 minutes hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design that doesn’t require extra equipment like a refrigerator, and a proprietary PCR technology allowing fast and accurate diagnostics, VitaPCR™ allows the detection of SARS-CoV-2 in 20 minutes from sample to results, at the Point-of-Care.

VitaPCR™ empowers practitioners with the right information at the right time, so they can make the right decision and provide the right course of treatment to the patients.

  • Ease of use no training required for operation

  • Convenient room temperature storage for reagent

  • Intuitive result interpretation with Ct Value & Fluorescence Curve

  • Diagnose COVID-19 with confidence at Point-of-care

  • Immediate results for faster triage & quarantine

VitaPCR IVD2x

For use under Emergency Use Authorization (EUA) only

 

 

 GENERAL DIAGNOSTIC PROCEDURE

 
GENERAL DIAGNOSTIC PROCEDURE 01024x GENERAL DIAGNOSTIC PROCEDURE 0304FDA4x copy

 

INTUITIVE RESULT INTERPRETATION

 

Flyer VitaPCR 1440x400

 



 

 

 SC2 Gen2 fix border

 

 

VitaPCR™ SARS-CoV-2 Gen 2 Assay Specifications
Catalog No. PCRAE0118
Technology Real-Time RT-PCR
Targets N1, N2 – Nucleocapsid Gene
Quantity 20 tests/box
Sample Types Nasopharyngeal or Oropharyngeal Swabs
Hands-on Time < 1 min
Turnaround Time 20 mins
Kit Storage 5 - 25 °C / 41 - 77 °F

 

Reference

  1. Trigt RV, Neat J, Brouwer JL, Hays A, Westerhof H. Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety. Bioanalysis. 2021;10.4155/bio-2021-0079.

  2. Musumeci A, Vinci M, L'Episcopo F, et al. Implementation of Sample Pooling Procedure Using a Rapid SARS-CoV-2 Diagnostic Real-Time PCR Test Performed Prior to Hospital Admission of People with Intellectual Disabilities. Int J Environ Res Public Health. 2021;18(17):9317.

  3. Fournier PE, Edouard S, Wurtz N, et al. Contagion Management at the Méditerranée Infection University Hospital InstituteJ Clin Med. 2021;10(12):2627.

  4. Fitoussi, F., Dupont, R., Tonen-Wolyec, S., & Bélec, L. (2021). Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France. Journal of medical virology, 93(7), 4351–4357.

  5. Fournier PE, Zandotti C, Ninove L, et al. Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19. J Clin Virol. 2020;133:104682.

 

icon sheet

Technical Documents

downloadFACT SHEET FOR HEALTHCARE PROVIDERS

downloadFACT SHEET FOR PATIENTS

 

 

icon report contact

Adverse Event Reporting →


Credo Diagnostic Biomedical

1 Fifth Avenue, Guthrie house #02-09, Singapore 268802
Phone: +886-2-2697-2728
Email: service@credodxbiomed.com

CONTACT

We at Credo Diagnostics pioneer accessible diagnostic platforms to improve the lives of those we love. We believe providing the right information to the right people at the right time leads to better outcomes.